Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

From thymus to tissues and tumors: A review of T-cell biology

Journal of Allergy and Clinical Immunology(2022)10.1016/j.jaci.2022.10.011Source: DataRank Database

From thymus to tissues and tumors: A review of T-cell biology is a research paper published in Journal of Allergy and Clinical Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 78 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access78 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 5.50)OA: greenTopics (28)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Christopher Redmond ORCID,John J. O’Shea ORCID,Daniella M. Schwartz ORCID,Laura B. Chopp ORCID

Live enrichment

PubMed:36272581 PMC:PMC9825672 OpenAlex:https://openalex.org/W4306804988

Intramural NIH HHS

Grant: Z99 AI999999

Intramural NIH HHS

Grant: ZIA AI001251

FWCI

5.50

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9825672

publisherhttps://api.elsevier.com/content/article/PII:S0091674922013781?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091674922013781?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaci.2022.10.011

Fields of Study

CAR-T cell therapy researchT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

MeSH Terms

HumansImmunity, CellularNeoplasmsT-LymphocytesCytokinesCD8-Positive T-LymphocytesAdaptive Immunity

Keywords

Immune systemT cellBiologyImmunologyDiseaseAcquired immune systemImmunityEffectorImmunotherapyPhenotypeMedicineGeneGeneticsPathologyT cellsCD4CD8adaptive immunity

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of The spleen is the graveyard of CD4+ cells in patients with immunological failure of visceral leishmaniasis and AIDS

10.6084/m9.figshare.26693940.v1figshare

Additional file 1 of The spleen is the graveyard of CD4+ cells in patients with immunological failure of visceral leishmaniasis and AIDS

10.6084/m9.figshare.26693940figshare

Additional file 2 of The spleen is the graveyard of CD4+ cells in patients with immunological failure of visceral leishmaniasis and AIDS

10.6084/m9.figshare.26693943.v1figshare

Additional file 2 of The spleen is the graveyard of CD4+ cells in patients with immunological failure of visceral leishmaniasis and AIDS

10.6084/m9.figshare.26693943figshare